Related Experiment Video
Updated: Oct 10, 2025

Author Spotlight: Exploring the Mysteries of Sichuan's Herbal Medicine in Chinese Medicine Research
Published on: March 1, 2024
Duodenal microbiota makes an important impact in functional dyspepsia
Yi-Feng Zheng1, Shu-Ping Liang1, Zi-Shao Zhong2
1Guangzhou University of Chinese Medicine, Guangzhou, China.
Functional Dyspepsia is linked to significant differences in duodenal microbiota. Researchers found altered microbial diversity, composition, and function in patients compared to healthy individuals, suggesting a role for duodenal microecology in FD.
Area of Science:
- Gastroenterology
- Microbiome Research
- Human Health
Background:
- Functional Dyspepsia (FD) is a common gastrointestinal disorder with multifactorial etiology.
- The role of duodenal microbiota in FD pathogenesis remains incompletely understood.
Purpose of the Study:
- To investigate differences in duodenal mucosal microbiota between FD patients and healthy controls.
- To identify specific microbial taxa and functional pathways associated with FD.
Main Methods:
- Duodenal mucosa and content samples collected via upper gastrointestinal endoscopy from 20 FD patients and 5 healthy subjects.
- Microbiome analysis using 16S rRNA gene sequencing.
- Statistical analysis including LEfSe, FAPROTAX, SPSS, PCoA, and AMOVA.
Main Results:
- Significant differences in microbial diversity (ACE, Shannon, Observed Species indices) and structure (PCoA, AMOVA) between FD patients and controls (P < 0.05).
- Distinct differences in the abundance of specific genera, including Alloprevotella, Peptostreptococcus, Sutterella, and Faecalibacterium.
- Altered duodenal bacterial functions, notably urea decomposition (ureolysis) and fumaric acid respiration, were observed in FD patients (P < 0.05).
Conclusions:
- Duodenal mucosal microbiota composition, diversity, and function are significantly altered in Functional Dyspepsia patients.
- These dysbiotic changes suggest that duodenal microecological disorders may contribute to the development of FD.
- Targeting duodenal microbiota could offer novel therapeutic strategies for Functional Dyspepsia.
More Related Videos
Related Concept Videos
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
Peptic Ulcer Disease I: Introduction
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Peptic Ulcer Disease II: Pathophysiology
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Pathophysiology of Peptic Ulcer Disease: Injurious Factors
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.

